Arrowhead Pharmaceuticals (ARWR) Invested Capital (2012 - 2026)
Arrowhead Pharmaceuticals (ARWR) posted Invested Capital of $40.0 million for Q1 2026, little changed on a QoQ basis from $40.0 million in Q4 2025, and down 38.46% year-over-year from $65.0 million in Q1 2025.
Arrowhead Pharmaceuticals (ARWR) Invested Capital (2012 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals' Invested Capital history runs 5 years deep, the most recent figure standing at $40.0 million for Q1 2026.
- Quarterly Invested Capital fell 38.46% year-over-year to $40.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $160.0 million (up 140.15% YoY) and the FY2025 annual result came in at $40.0 million, changed N/A from the prior year.
- Invested Capital was $40.0 million for Q1 2026 at Arrowhead Pharmaceuticals, roughly flat from $40.0 million in the prior quarter.
- Across five years, Invested Capital topped out at $65.0 million in Q1 2025 and bottomed at $1.6 million in Q4 2024.
- A 3-year average of $37.8 million and a median of $40.0 million in 2025 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2025 — Invested Capital surged 2361.54% — and 2026, when it sank 38.46%.
- Arrowhead Pharmaceuticals' Invested Capital stood at $1.6 million in 2024, then jumped by 2361.54% to $40.0 million in 2025, then changed by 0.0% to $40.0 million in 2026.
- Business Quant data shows ARWR's Invested Capital at $40.0 million in Q1 2026, $40.0 million in Q4 2025, and $40.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 116.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arrowhead Pharmaceuticals | 11.98 Bn | 10.18 Bn | - | 40.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.00 Mn |
| Dec 31, 2025 | 40.00 Mn |
| Sep 30, 2025 | 40.00 Mn |
| Jun 30, 2025 | 40.00 Mn |
| Mar 31, 2025 | 65.00 Mn |
| Dec 31, 2024 | 1.63 Mn |
| Dec 31, 2013 | 1.23 Mn |
| Sep 30, 2013 | 1.28 Mn |
| Jun 30, 2013 | 1.34 Mn |
| Mar 31, 2013 | 1.39 Mn |
| Jun 30, 2012 | 1.55 Mn |